Related Experiment Videos
Midadult women's attitudes about receiving the prophylactic human papillomavirus vaccine
Daron G Ferris1, Jennifer L Waller, Ashley Owen
1Gynecologic Cancer Prevention Center, Departments of Family Medicine and Obstetrics and Gynecology, Medical College of Georgia, Augusta, GA 30912, USA. dferris@mcg.edu
Objective:
To determine midadult (age, > or =25 years) women's attitudes about receiving the prophylactic human papillomavirus (HPV) vaccine.
Materials And Methods:
Four hundred seventy-two women 25 years or older completed a 46-question survey, read an educational sheet about HPV and HPV vaccines, and then completed a 23-item survey. Frequency data were reported, and interventional effects measured by Bowker test of symmetry.
Results:
After educational intervention, 50% of mid-adult women wanted to receive the vaccine, and 34.3% were undecided. A desire to be healthy (48.9%), prevent cervical cancer (42.8%), and fear of cervical cancer (35.8%) were the most common reasons for wanting the vaccine. The main reasons for not wanting the vaccine included being in a monogamous relationship (29.5%), not being at risk for acquiring HPV (15.0%), and practicing safe sex (10.8%).
Conclusions:
Midadult women have a high level of acceptance for the HPV vaccine. Our findings help support future implementation of the vaccine in this catch-up population of receptive women.
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Vaccinations
Mitral Valve Prolapse III: Nursing Management
Vaccines
Preventive Healthcare Services
Birth Control Methods